logo

GUTS

Fractyl Health·NASDAQ
--
--(--)
--
--(--)

GUTS fundamentals

Fractyl Health (GUTS) released its earnings on Mar 24, 2026: revenue was 0 (YoY -100.00%), met estimates; EPS was -0.17 (YoY +67.31%), beat estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.17
+67.31%
Report date
Mar 24, 2026
GUTS Earnings Call Summary for Q4,2025
  • Revita Efficacy Breakthrough: 16+ cm ablation reduces weight regain by 70%, with 88% weight loss retention in high responders. Pivotal study >90% powered for success.
  • FDA De Novo Pathway: Favorable feedback received, enabling faster, capital-efficient clearance with 6-month data submission in Q4 2026.
  • Financial Strength: $85.6M cash runway funds operations into 2027, eliminating need for capital raise before pivotal readout.
  • Commercial Momentum: CPT code filing in Q2 2026, CMS Pass-Through Payment ensures hospital economics, targeting 30M+ GLP-1 users.

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Fractyl Health (GUTS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Fractyl Health (GUTS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Fractyl Health (GUTS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Fractyl Health (GUTS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Fractyl Health (GUTS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Fractyl Health (GUTS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield